These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 34035369)

  • 1. Identification of hepatic fibrosis inhibitors through morphometry analysis of a hepatic multicellular spheroids model.
    Song Y; Kim S; Heo J; Shum D; Lee SY; Lee M; Kim AR; Seo HR
    Sci Rep; 2021 May; 11(1):10931. PubMed ID: 34035369
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of DNMT3B expression in activated hepatic stellate cells overcomes chemoresistance in the tumor microenvironment of hepatocellular carcinoma.
    Song Y; Kim N; Heo J; Shum D; Heo T; Seo HR
    Sci Rep; 2024 Jan; 14(1):115. PubMed ID: 38168140
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Role of Fibrosis and Liver-Associated Fibroblasts in the Pathogenesis of Hepatocellular Carcinoma.
    Baglieri J; Brenner DA; Kisseleva T
    Int J Mol Sci; 2019 Apr; 20(7):. PubMed ID: 30959975
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patient-derived multicellular tumor spheroids towards optimized treatment for patients with hepatocellular carcinoma.
    Song Y; Kim JS; Kim SH; Park YK; Yu E; Kim KH; Seo EJ; Oh HB; Lee HC; Kim KM; Seo HR
    J Exp Clin Cancer Res; 2018 May; 37(1):109. PubMed ID: 29801504
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inflammatory microenvironment of fibrotic liver promotes hepatocellular carcinoma growth, metastasis and sorafenib resistance through STAT3 activation.
    Jiang Y; Chen P; Hu K; Dai G; Li J; Zheng D; Yuan H; He L; Xie P; Tu M; Peng S; Qu C; Lin W; Chung RT; Hong J
    J Cell Mol Med; 2021 Feb; 25(3):1568-1582. PubMed ID: 33410581
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activated hepatic stellate cells play pivotal roles in hepatocellular carcinoma cell chemoresistance and migration in multicellular tumor spheroids.
    Song Y; Kim SH; Kim KM; Choi EK; Kim J; Seo HR
    Sci Rep; 2016 Nov; 6():36750. PubMed ID: 27853186
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Three Dimensional Mixed-Cell Spheroids Mimic Stroma-Mediated Chemoresistance and Invasive Migration in hepatocellular carcinoma.
    Khawar IA; Park JK; Jung ES; Lee MA; Chang S; Kuh HJ
    Neoplasia; 2018 Aug; 20(8):800-812. PubMed ID: 29981501
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatocellular carcinoma cells and their fibrotic microenvironment modulate bone marrow-derived mesenchymal stromal cell migration in vitro and in vivo.
    Garcia MG; Bayo J; Bolontrade MF; Sganga L; Malvicini M; Alaniz L; Aquino JB; Fiore E; Rizzo MM; Rodriguez A; Lorenti A; Andriani O; Podhajcer O; Mazzolini G
    Mol Pharm; 2011 Oct; 8(5):1538-48. PubMed ID: 21770423
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modelling the Sorafenib-resistant Liver Cancer Microenvironment by Using 3-D Spheroids.
    Sariyar E; Firtina Karagonlar Z
    Altern Lab Anim; 2023 Sep; 51(5):301-312. PubMed ID: 37555318
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fasting inhibits hepatic stellate cells activation and potentiates anti-cancer activity of Sorafenib in hepatocellular cancer cells.
    Lo Re O; Panebianco C; Porto S; Cervi C; Rappa F; Di Biase S; Caraglia M; Pazienza V; Vinciguerra M
    J Cell Physiol; 2018 Feb; 233(2):1202-1212. PubMed ID: 28471474
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polaprezinc inhibits liver fibrosis and proliferation in hepatocellular carcinoma.
    Ye J; Zhang Z; Zhu L; Lu M; Li Y; Zhou J; Lu X; Du Q
    Mol Med Rep; 2017 Oct; 16(4):5523-5528. PubMed ID: 28849143
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CRIPTO promotes an aggressive tumour phenotype and resistance to treatment in hepatocellular carcinoma.
    Karkampouna S; van der Helm D; Gray PC; Chen L; Klima I; Grosjean J; Burgmans MC; Farina-Sarasqueta A; Snaar-Jagalska EB; Stroka DM; Terracciano L; van Hoek B; Schaapherder AF; Osanto S; Thalmann GN; Verspaget HW; Coenraad MJ; Kruithof-de Julio M
    J Pathol; 2018 Jul; 245(3):297-310. PubMed ID: 29604056
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activation of ferritinophagy is required for the RNA-binding protein ELAVL1/HuR to regulate ferroptosis in hepatic stellate cells.
    Zhang Z; Yao Z; Wang L; Ding H; Shao J; Chen A; Zhang F; Zheng S
    Autophagy; 2018; 14(12):2083-2103. PubMed ID: 30081711
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CCN1/Cyr61 enhances the function of hepatic stellate cells in promoting the progression of hepatocellular carcinoma.
    Li ZQ; Wu WR; Zhao C; Zhao C; Zhang XL; Yang Z; Pan J; Si WK
    Int J Mol Med; 2018 Mar; 41(3):1518-1528. PubMed ID: 29286082
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Suberoylanilide Hydroxamic Acid (SAHA) Reduces Fibrosis Markers and Deactivates Human Stellate Cells via the Epithelial-Mesenchymal Transition (EMT).
    Özel M; Baskol M; Akalın H; Baskol G
    Cell Biochem Biophys; 2021 Jun; 79(2):349-357. PubMed ID: 33689126
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential effects of arsenic trioxide on chemosensitization in human hepatic tumor and stellate cell lines.
    Rangwala F; Williams KP; Smith GR; Thomas Z; Allensworth JL; Lyerly HK; Diehl AM; Morse MA; Devi GR
    BMC Cancer; 2012 Sep; 12():402. PubMed ID: 22963400
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The herbal compound Songyou Yin (SYY) inhibits hepatocellular carcinoma growth and improves survival in models of chronic fibrosis via paracrine inhibition of activated hepatic stellate cells.
    Bu Y; Jia QA; Ren ZG; Xue TC; Zhang QB; Zhang KZ; Zhang QB; You Y; Tian H; Qin LX; Tang ZY
    Oncotarget; 2015 Nov; 6(37):40068-80. PubMed ID: 26517671
    [TBL] [Abstract][Full Text] [Related]  

  • 18. AZGP1 suppresses epithelial-to-mesenchymal transition and hepatic carcinogenesis by blocking TGFβ1-ERK2 pathways.
    Xu MY; Chen R; Yu JX; Liu T; Qu Y; Lu LG
    Cancer Lett; 2016 May; 374(2):241-9. PubMed ID: 26902423
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased expression of SLC46A3 to oppose the progression of hepatocellular carcinoma and its effect on sorafenib therapy.
    Zhao Q; Zheng B; Meng S; Xu Y; Guo J; Chen LJ; Xiao J; Zhang W; Tan ZR; Tang J; Chen L; Chen Y
    Biomed Pharmacother; 2019 Jun; 114():108864. PubMed ID: 30981107
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatic stellate cells and extracellular matrix in hepatocellular carcinoma: more complicated than ever.
    Carloni V; Luong TV; Rombouts K
    Liver Int; 2014 Jul; 34(6):834-43. PubMed ID: 24397349
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.